Intercept Pharmaceuticals Inc. (ICPT) Enters Overbought Territory - Tale of the Tape
Intercept Pharmaceuticals Inc. ( ICPT ) has moved higher as of late, but there could definitely be trouble on the horizon for this company. That is because ICPT is now in overbought territory with an RSI value of 71.5 . Furthermore, Intercept Pharmaceuticals Inc. currently has a Zacks Rank #4 (Sell) , suggesting that investors may want to consider exiting this stock now before it falls back to Earth.
INTERCEPT PHARM (ICPT): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research